Literature DB >> 27012295

Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years.

W Brinjikji1, V N Iyer2, V Yamaki2, G Lanzino3, H J Cloft4, K R Thielen4, K L Swanson5, C P Wood4.   

Abstract

BACKGROUND AND
PURPOSE: Hereditary hemorrhagic telangiectasia is associated with a wide range of neurovascular abnormalities. The aim of this study was to characterize the spectrum of cerebrovascular lesions, including brain arteriovenous malformations, in patients with hereditary hemorrhagic telangiectasia and to study associations between brain arteriovenous malformations and demographic variables, genetic mutations, and the presence of AVMs in other organs.
MATERIALS AND METHODS: Consecutive patients with definite hereditary hemorrhagic telangiectasia who underwent brain MR imaging/MRA, CTA, or DSA at our institution from 2001 to 2015 were included. All studies were re-evaluated by 2 senior neuroradiologists for the presence, characteristics, location, and number of brain arteriovenous malformations, intracranial aneurysms, and nonshunting lesions. Brain arteriovenous malformations were categorized as high-flow pial fistulas, nidus-type brain AVMs, and capillary vascular malformations and were assigned a Spetzler-Martin score. We examined the association between baseline clinical and genetic mutational status and the presence/multiplicity of brain arteriovenous malformations.
RESULTS: Three hundred seventy-six patients with definite hereditary hemorrhagic telangiectasia were included. One hundred ten brain arteriovenous malformations were noted in 48 patients (12.8%), with multiple brain arteriovenous malformations in 26 patients. These included 51 nidal brain arteriovenous malformations (46.4%), 58 capillary vascular malformations (52.7%), and 1 pial arteriovenous fistula (0.9%). Five patients (10.4%) with single nidal brain arteriovenous malformation presented with hemorrhage. Of brain arteriovenous malformations, 88.9% (88/99) had a Spetzler-Martin score of ≤2. Patients with brain arteriovenous malformations were more likely to be female (75.0% versus 57.6%, P = .01) and have a family history of hereditary hemorrhagic telangiectasia (95.8% versus 84.8%, P = .04). The prevalence of brain arteriovenous malformation was 19.7% in endoglin (ENG) mutations and 12.5% in activin receptor-like kinase (1ACVRL1) mutations.
CONCLUSIONS: Our study of 376 patients with hereditary hemorrhagic telangiectasia demonstrated a high prevalence of brain arteriovenous malformations. Nidal brain arteriovenous malformations and capillary vascular malformations occurred in roughly equal numbers.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 27012295      PMCID: PMC7960275          DOI: 10.3174/ajnr.A4762

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  23 in total

1.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

Authors:  T G W Letteboer; J J Mager; R J Snijder; B P C Koeleman; D Lindhout; J K Ploos van Amstel; C J J Westermann
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features.

Authors:  M Salaria; J Taylor; M Bogwitz; I Winship
Journal:  Intern Med J       Date:  2014-07       Impact factor: 2.048

3.  Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008.

Authors:  C F Ni Bhuachalla; T M O' Connor; M Murphy; N Colwell; A Brady
Journal:  Respir Med       Date:  2010-04-01       Impact factor: 3.415

4.  Spontaneous intracerebral hemorrhage caused by an unusual association of developmental venous anomaly and arteriovenous malformation.

Authors:  K F Fok; S Holmin; H Alvarez; A Ozanne; T Krings; P L Lasjaunias
Journal:  Interv Neuroradiol       Date:  2006-07-31       Impact factor: 1.610

5.  In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.

Authors:  Yuan Zhu; Qun Wu; Moritz Fass; Jin-Fang Xu; Chao You; Oliver Müller; I Erol Sandalcioglu; Jian-Min Zhang; Ulrich Sure
Journal:  Neurosurgery       Date:  2011-09       Impact factor: 4.654

6.  Cerebral vascular malformations in hereditary hemorrhagic telangiectasia.

Authors:  M Neil Woodall; Melissa McGettigan; Ramon Figueroa; James R Gossage; Cargill H Alleyne
Journal:  J Neurosurg       Date:  2013-11-15       Impact factor: 5.115

7.  Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia.

Authors:  S Al-Saleh; M Mei-Zahav; M E Faughnan; I B MacLusky; S Carpenter; M Letarte; F Ratjen
Journal:  Eur Respir J       Date:  2009-04-22       Impact factor: 16.671

8.  The association between high VEGF levels and multiple probable punctuate cavernous malformations.

Authors:  Tatsuya Abe; M Morishige; H Ooba; T Kamida; M Fujiki; H Kobayashi; T Sakoda; Y Kimba
Journal:  Acta Neurochir (Wien)       Date:  2009-05-29       Impact factor: 2.216

9.  Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation.

Authors:  Qi Hao; Hua Su; Douglas A Marchuk; Radoslaw Rola; Yongqiang Wang; Weizhong Liu; William L Young; Guo-Yuan Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

10.  Brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: clinical presentation and anatomical distribution.

Authors:  Maha Saleh; Melissa T Carter; Giuseppe A Latino; Peter Dirks; Felix Ratjen
Journal:  Pediatr Neurol       Date:  2013-09-27       Impact factor: 3.372

View more
  11 in total

1.  Prevalence of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia: Report from a Single Reference Center.

Authors:  M S Perez Akly; C Vazquez; C H Besada; M J Rodriguez; M F Conde; A R Cajal; V A Peuchot; D Dardik; M M Baccanelli; M M Serra
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

2.  Combined transarterial and transvenous embolization of multi-hole pial arteriovenous fistula with large varix.

Authors:  Hiroki Yamada; Takenori Akiyama; Dai Kamamoto; Keisuke Yoshida; Mariko Fukumura; Masahiro Toda
Journal:  Neuroradiol J       Date:  2022-04-28

Review 3.  Systemic and CNS manifestations of inherited cerebrovascular malformations.

Authors:  Blaine L Hart; Marc C Mabray; Leslie Morrison; Kevin J Whitehead; Helen Kim
Journal:  Clin Imaging       Date:  2021-01-20       Impact factor: 2.420

4.  European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Omer F Eker; Edoardo Boccardi; Ulrich Sure; Maneesh C Patel; Saverio Alicante; Ali Alsafi; Nicola Coote; Freya Droege; Olivier Dupuis; Annette Dam Fialla; Bryony Jones; Ujwal Kariholu; Anette D Kjeldsen; David Lefroy; Gennaro M Lenato; Hans Jurgen Mager; Guido Manfredi; Troels H Nielsen; Fabio Pagella; Marco C Post; Catherine Rennie; Carlo Sabbà; Patrizia Suppressa; Pernille M Toerring; Sara Ugolini; Elisabetta Buscarini; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2020-06-29       Impact factor: 4.123

5.  Patients with in-situ metallic coils and Amplatzer vascular plugs used to treat pulmonary arteriovenous malformations since 1984 can safely undergo magnetic resonance imaging.

Authors:  Ali Alsafi; James E Jackson; Gavin Fatania; Maneesh C Patel; Alan Glover; Claire L Shovlin
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

6.  Gender differences in hereditary hemorrhagic telangiectasia severity.

Authors:  J M Mora-Luján; A Iriarte; E Alba; M A Sánchez-Corral; P Cerdà; F Cruellas; Q Ordi; X Corbella; J Ribas; J Castellote; A Riera-Mestre
Journal:  Orphanet J Rare Dis       Date:  2020-03-02       Impact factor: 4.123

Review 7.  Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia.

Authors:  Carmelo Bernabeu; Pinar Bayrak-Toydemir; Jamie McDonald; Michelle Letarte
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

8.  Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia.

Authors:  K P Thompson; J Nelson; H Kim; S M Weinsheimer; D A Marchuk; M T Lawton; T Krings; M E Faughnan
Journal:  Orphanet J Rare Dis       Date:  2021-09-19       Impact factor: 4.123

Review 9.  Imaging to intervention: a review of what the Interventionalist needs to Know about Hereditary Hemorrhagic Telangiectasia.

Authors:  Stephanie Sobrepera; Eric Monroe; Joseph J Gemmete; Danial Hallam; Jason W Pinchot; Claire Kaufman
Journal:  CVIR Endovasc       Date:  2021-12-09

10.  Pathologically Complete Response after Triple Therapy in Locally Advanced Esophageal Cancer in a Hereditary Hemorrhagic Telangiectasia Patient.

Authors:  Robin Park; Alisdair Philp; Alykhan S Nagji; Anup Kasi
Journal:  Case Rep Oncol       Date:  2020-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.